Viewing Study NCT02187250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-02-08 @ 11:07 AM
Study NCT ID: NCT02187250
Status: COMPLETED
Last Update Posted: 2014-07-10
First Post: 2014-07-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
Sponsor: University Medical Centre Ljubljana
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None PCOS View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metformin View
None PCOS View
None PDE-4 inhibitor View
None roflumilast View
None liraglutide View
None obesity View